| Let it Flow | Antibiotics Collateral Damage | Respiratory | |
|---|---|---|---|
|
What is bactrim DS BID x 14 days, Ciprofloxacin 500mg BID x 7 days
The 2 medication regimens are appropriate for pyelonephritis treatment
|
What is 20%
the community pathogen resistance level at which an antibiotic should no longer be used for treatment (%)
|
What is fidaxomicin 200mg BID x 10 days
the first line treatment regimen for CDiff
|
What is Augmentin 875/125 BID x 7 days and macrolide or doxycycline
or fluoroquinolone
The outpatient regimen for CAP treatment in patients with comorbidities
|
|
What is EColi
Proteus mirabilis Klebsiella pneumoniae, Staphylococcus saprophyticus
The most common pathogen for UTI
|
What is MRSA and Pseudomonas Aeruginosa
Use of fluoroquinolones to treat uncomplicated UTIs increases the risk of infection with what 2 resistant pathogens
|
What is no antibiotics unless empyema or abscess suspected
the treatment regimen for aspiration pneumonia
|
|
|
What is bactrim DS BID x 3 days
macrobid 100mg BID x 5 days fosfomycin 3g single dose, no FQ due to propensity for collateral damage Pivmecillinam 400mg BID x 5 days
2 most common regimens for acute uncomplicated cystitis
|
What is VRE
Use of broad spectrum cephalosporins to treat uncomplicated UTIs increases the risk of infection with what resistant pathogen
|
||
|
What is ciprofloxacin 500mg BID
Bactrim DS BID 2-4 weeks
the treatment regimen for a patient if you suspect acute bacterial prostatitis (non-sexually transmitted)
|
|||
|
What is single dose IM ceftriaxone and doxycycline 100mg BID x 2 weeks
the treatment regimen for a patient if you suspect acute bacterial prostatitis sexually transmitted
|
|||
Support Us on Ko-fi